Kimura M, Goto S, Ihara Y, Wada A, Yahiro K, Niidome T, et al
4 Unfortunately, with the surge in semaglutide and related prescriptions, which has been exacerbated by compounded (see below) GLP-1 drugs also reaching the public, there has been a surge in calls tracked by Americas Poison Centers, reaching almost 3,000 calls in 2023
Devasagayam TP, Kamat JP, Mohan H, Kesavan PC (1996) Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species
Doctors may be able to: suggest alternative medications recommend pharmacy pricing comparisons help complete insurance appeal documentation provide information about assistance programs Healthcare professionals are familiar with these challenges and may be able to help patients navigate options that make treatment more manageable
Blood tests including serum B12, full blood count, and folate levels guide appropriate supplementation
Back to Journals Drug Design, Development and Therapy Volume 19 A Comprehensive Review on the Pharmacokinetics and DrugDrug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist Authors Min JS, Jo SJ, Lee S, Kim DY, Kim DH, Lee CB , Bae SK Received 17 November 2024 Accepted for publication 14 April 2025 Published 30 April 2025 Volume 2025:19 Pages 35093537 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Prof